NCT01020877View on ClinicalTrials.gov

Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

November 30, 2001

Study Completion Date

January 31, 2002

Conditions
Healthy
Interventions
DRUG

Metronidazole

Vaginal Gel, 0.75%

DRUG

Metronidazole

Vaginal Gel, 0.75%

Trial Locations (1)

15206

Novum Pharmaceutical Research Services, Pittsburgh

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01020877 - Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects | Biotech Hunter | Biotech Hunter